हॉजकिन लिम्फोमा (Hodgkin lymphoma)
A chemotherapy response adapted management of an intense standard of care treatment regimen of classical Hodgkin Lymphoma in children, where the radiation therapy can be omitted based on the risk assessed through Positron Emission and Computerized Tomography imaging technique
हॉस्पिटलशी संपर्क साधा
रजिस्ट्रीमध्ये या हॉस्पिटलला ट्रायलचा मुख्य संपर्क म्हणून दिलं आहे. कोणते हॉस्पिटल्स रुग्ण घेत आहेत, हे त्यांना विचारा.
रजिस्ट्री सारांश (तांत्रिक)
Response-Adapted Management of Childhood Classical Hodgkin Lymphoma (cHL) and Early Response Assessment by Positron Emission and Computerized Tomography (PET-CT) to allow Omission of Radiotherapy in Indian Children Treated with a Standard of Care Intensified Chemotherapy Regimen
Sponsor: Dr Gaurav Narula Professor Medical OncologyPediatrics Unit Tata Memorial Hospital
CTRI, India's trial registry वर CTRI/2020/08/027495
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, 12 Oct 2026 चा data
Registry वर 30 Mar 2026 ला शेवटचे update झाले · आम्ही 5 Nov 2026 ला वाचले